France - Laboratoire Actions Innovations Marines (A.I.M) - Groupe Gerolymatos S.A.S.

Our Group’s involvement with Laboratoire A.I.M. begun in 2005 in the form of a Joint Venture. Over the years, our involvement in the company increased and our Group’s participation is now 100% of the share capital. Laboratoire A.I.M. focuses on the pumping and processing of sea water, the essential raw material for the production of all our sea water-based products. Aside from our Group’s products, Laboratoire A.I.M. also supplies sea water to a number of companies with well-established sea water-based brands, and is thus recognized as a reliable raw material supplier in this market. Laboratoire A.I.M. pumps and processes sea water from a licensed installation in the bay of Cancale, on the French coast of Brittany. The north of Brittany experiences some of the strongest tidal action in the world. This huge and constant movement of sea water ensures it is continuously renewed, enriched with mineral salts & trace elements and oxygenated. The area is continuously monitored by the French Research Institute for Exploitation of the Sea (IFREMER) under the auspices of the French Government. Together with A.I.M.’s ISO 9001:2015 certification, this ensures sea water of the highest quality, enabling us and our customers to obtain pharmaceutical registration of our final products wherever it is necessary to do so. Strategically, this vertical integration enhances our Group’s control over the raw material that is essential for the production of our core product line, Sinomarin®, both in terms of undisrupted supply and in terms of the exceptional quality of the raw material.

Italy - Foltene Laboratories S.p.A.

Foltène® Laboratories S.r.l., located in Como, Italy, was originally a subsidiary of Crinos Industria Farmacobiologica S.p.A., an Italian pharmaceutical company founded in 1944. Foltène® Laboratories S.r.l. is a 100% owned subsidiary of Gerolymatos International S.A. and is recognized as a major global player with a long tradition in the development and commercialization of innovative safe and effective cosmetic hair products for hair loss prevention and treatment of certain scalp conditions. The company's key brand include anti-hair loss treatments for men and women based on Tricosaccaride, a mixture of mucopolysaccharides and Tricalgoxyl, a mixture of oligosaccharides extracted from brown algae. The company’s unique products –presented mainly in the pharmacy channel under the Foltène® Pharma brand– capitalize on experience derived through more than 70 years of research and 42 published clinical studies, and have received global recognition placing Foltène® in a strong market position internationally. The brand is present in over 30 markets worldwide and is envisioning its future international expansion in new markets at a fast while steady pace. Foltène® will continue to hold long lasting partnerships around the world, providing high quality products recognized and respected by end consumers, competitors and internal & external stakeholders.